1. Home
  2. PODD vs FNF Comparison

PODD vs FNF Comparison

Compare PODD & FNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • FNF
  • Stock Information
  • Founded
  • PODD 2000
  • FNF 1847
  • Country
  • PODD United States
  • FNF United States
  • Employees
  • PODD N/A
  • FNF N/A
  • Industry
  • PODD Medical/Dental Instruments
  • FNF Specialty Insurers
  • Sector
  • PODD Health Care
  • FNF Finance
  • Exchange
  • PODD Nasdaq
  • FNF Nasdaq
  • Market Cap
  • PODD 16.5B
  • FNF 16.5B
  • IPO Year
  • PODD 2007
  • FNF N/A
  • Fundamental
  • Price
  • PODD $260.12
  • FNF $60.73
  • Analyst Decision
  • PODD Buy
  • FNF Buy
  • Analyst Count
  • PODD 15
  • FNF 6
  • Target Price
  • PODD $251.53
  • FNF $59.67
  • AVG Volume (30 Days)
  • PODD 609.1K
  • FNF 1.1M
  • Earning Date
  • PODD 11-07-2024
  • FNF 11-06-2024
  • Dividend Yield
  • PODD N/A
  • FNF 3.16%
  • EPS Growth
  • PODD 235.68
  • FNF 29.08
  • EPS
  • PODD 5.74
  • FNF 2.76
  • Revenue
  • PODD $1,983,900,000.00
  • FNF $13,530,000,000.00
  • Revenue This Year
  • PODD $22.33
  • FNF N/A
  • Revenue Next Year
  • PODD $18.50
  • FNF $9.39
  • P/E Ratio
  • PODD $45.35
  • FNF $22.03
  • Revenue Growth
  • PODD 27.42
  • FNF 23.81
  • 52 Week Low
  • PODD $160.19
  • FNF $44.10
  • 52 Week High
  • PODD $279.40
  • FNF $62.97
  • Technical
  • Relative Strength Index (RSI)
  • PODD 63.27
  • FNF 54.94
  • Support Level
  • PODD $233.48
  • FNF $60.56
  • Resistance Level
  • PODD $276.57
  • FNF $61.83
  • Average True Range (ATR)
  • PODD 8.53
  • FNF 1.32
  • MACD
  • PODD 2.16
  • FNF 0.11
  • Stochastic Oscillator
  • PODD 63.19
  • FNF 79.56

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About FNF FNF Group of Fidelity National Financial Inc.

Fidelity National Financial Inc provides title insurance, escrow, and other title-related services. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. Substantially all of the company's revenue is generated in the United States.

Share on Social Networks: